e Yugoslavia

Forest Laboratories, Inc. , an international pharmaceutical manufacturer and marketer, today announced that it has been granted European Medicines Agency (EMA) approval to market Colobreathe dry powder colistimethate sodium for inhalation for treating cystic fibrosis patients aged 6 years and older with chronic lung infection caused by P. aeruginosa.

Active Biotech’s and Ipsen’s castrate resistant prostate cancer project, TASQ, will be presented at the 27th Annual EAU Congress held in Paris on 24-28 February 2012. The presentation will detail the analysis of up to three years safety data from the TASQ Phase II study in chemotherapy-naïve metastatic castrate resistant prostate cancer (CRPC).

American Associated Pharmacies (AAP) announced on Wednesday its partnership with RxAlly, an alliance of more than 20,000 pharmacies nationwide. The largest Performance Network of aligned pharmacies in the country.

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market preservative-free Methotrexate Injection, USP. APP currently manufactures Methotrexate Injection with preservative.

Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that it has filed two patent infringement lawsuits against Cellectis SA and a number of its affiliates in the U.S. District Court for the Eastern District of North Carolina.

Takara Bio Europe today announced that it has joined forces with leading qPCR training provider TATAA Biocenter to offer free educational webinars in real-time PCR (qPCR) for academic and industrial researchers and laboratory technicians.

Plexxikon Inc., a member of Daiichi Sankyo Group, today announced that the European Commission has approved Zelboraf (vemurafenib) for the monotherapy treatment of adult patients with BRAFV600 mutation-positive unresectable or metastatic melanoma.

Stemedica Cell Technologies, Inc. (Stemedica), a leading manufacturer of adult allogeneic stem cells and stem cell factors announced that the Company has been issued U.S. Patent #8,105,380 by the United States Patent and Trademark Office.

SEMTech Solutions, a world leading supplier of used Scanning Electron Microscopes (SEMs) is pleased to announce the addition of Deborah M. Langlais as Vice President of our Analytical Testing Laboratory.

Nanologica AB today announced that the Company is a key player in the ORCHID project. The ORCHID alliance brings together tuberculosis (TB) expertise from academia, government research centres, non-profit organizations and biotech companies. The project is funded by European Union’s Seventh Framework Programme.